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Edited by Judit Ova´diAbstract a-Synuclein has been implicated in the pathogenesis
of Parkinson’s disease (PD). Heat shock proteins (HSPs) can re-
duce protein misfolding and accelerate the degradation of mis-
folded proteins. 1-methyl-4-phenylpyridinium ion (MPP+) is
the compound responsible for the PD-like neurodegeneration
caused by MPTP. In this study, we found that MPP+ could in-
crease the expression of a-synuclein mRNA but could not elevate
proteasome activity suﬃciently, leading to a-synuclein protein
accumulation followed by aggregation. Both HSPs and HDJ-
1, a homologue of human Hsp40, can inhibit MPP+-induced a-
synuclein mRNA expression, promote ubiquitination and elevate
proteasome activity. These ﬁndings suggest that HSPs may inhi-
bit the MPP+-induced a-synuclein expression, accelerate a-syn-
uclein degradation, thereby reducing the amount of a-synuclein
protein and accordingly preventing its aggregation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Three mutations (A30P, A53T and E46K) and genomic trip-
lication of a-synuclein were involved in familial Parkinson’s
disease (PD) [1–4]. The polymorphism of the a-synuclein gene
promoter region was associated with sporadic PD [5]. In
sporadic PD, oxidative stress, mitochondrial damage and high
concentrations of metal ions can upregulate the expression of a-
synuclein. a-Synuclein protein is prone to aggregate and form
ﬁlamentous ﬁbrils under high concentrations, oxidation, nitra-
tion and inhibition of proteasome [6–8]. Because a-synuclein
that has formed ﬁbrils is diﬃcult to be degraded by the normal
proteolytic pathway, it is transported into the microtubule
organizing center near the nuclear and wrapped with ubiquitin
and components of proteasomes by vimentin to form aggrea-
some which is similar to Lewy body [9,10]. a-Synuclein gene
transfected cells and animal models also developed the patho-Abbreviations: PD, Parkinson’s disease; HSPs, Heat shock proteins;
MPP+, 1-methyl-4-phenylpyridinium ion; BCA, bicinchoninic acid;
PCR, polymerase chain reaction; SDS, sodium dodecyl sulfate; HRP,
horseradish peroxidase; UPP, ubiquitin-proteasome pathway; MPTP,
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
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doi:10.1016/j.febslet.2006.04.057logical features and/or behavioral changes of PD [11,12]. All
of these ﬁndings demonstrate that a-synuclein may play an
important role in the initiation and development of PD.
Heat shock proteins (HSPs), acting as molecular chaperones,
are able to assist newly synthesized polypeptide chains fold cor-
rectly, preventing emergence of aggregation events. Addition-
ally, they assist in recovering of misfolded proteins, or guide
them to be degraded by the proteasome pathway or by the
autophagic pathway within lysosomes [13,14]. Recent studies
have revealed that HSPs can protect neurons from the degener-
ation in some neurodegenerative diseases, such as Alzheimer’s
disease [15], PD [16], Huntington’s disease [17] and Prion dis-
ease [18]. All of these diseases share a similar feature, that is,
conformational changes of proteins due to gene mutation or
excessively high concentration lead to incorrect folding fol-
lowed by aggregation which is toxic to the cells. A new concept
of protein conformational disease has been proposed to explain
the pathogenesis of neurodegenerative diseases [19]. This con-
cept proposes that some neurodegenerative disorders could be
cured by preventing proteins misfolding or by returning mis-
folded proteins to normal, or by accelerating the degradation
of aggregated proteins. Thus the role of HSPs as molecular
chaperones has sparked growing interests.
HDJ-1 is one of the human homologues of Hsp40. In cells
transfected with a-synuclein, over-expression of HDJ-1 can
signiﬁcantly reduce a-synuclein aggregation [20]. As 1-
methyl-4-phenylpyridinium ion (MPP+) is a widely used neu-
rotoxin to produce PD model, in this study, we explored the
eﬀects of HSPs induced by heat shock and transfected HDJ-
1 on the expression and aggregation of a-synuclein in MPP+-
treated SK-N-SH cells. We found that HSPs were able to
suppress MPP+-induced a-synuclein mRNA expression, in-
crease protein ubiquitination and elevate proteasome activity,
therefore decreasing the amounts of a-synuclein protein and
reducing its aggregation.2. Materials and methods
2.1. Cell cultures and heat shock treatment
Human neuroblastoma SK-N-SH cells were purchased from the Cell
Bank of the Shanghai Institute of Cell Biology and Biochemistry, Chi-
nese Academy of Sciences. The cells were cultured in DMEM-H med-
ium (Invitrogen, Grand Island, NY) containing 10% inactive FBS
(Invitrogen), 100 u/ml penicillin and 100 u/ml streptomycin (Invitro-
gen) at 37 C in an atmosphere of 5% CO2. For heat shock treatment,
the cells were incubated in a 41.5 C water bath for 1 h.blished by Elsevier B.V. All rights reserved.
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pcDNA3.1(+) plasmid was purchased from Invitrogen and
pcDNA3.1(+)/HDJ-1 plasmid was constructed in our lab. When cells
in 6-well plates grew up to 60% conﬂuence, DMEM medium was re-
placed by 500 ll OPTI-MEMI (Invitrogen) in each well. One micro-
gram of pcDNA3.1(+)/HDJ-1 and 3 ll Lipofectamine 2000
(Invitrogen) were added in 250 ll OPTI-MEMI, respectively. After
5 min, the solutions were mixed and allowed to stand for 25 min.
The ﬁnal mixture was added to each well and incubated at 37 C. After
5 h the medium was replaced by DMEM medium with serum. The
same method was used to transfect pcDNA3.1(+) vector as control.
2.3. Group and MPP+ treatment
SK-N-SH cells were divided into ﬁve groups: MPP+ group, heat
shock group, HDJ-1 transfected group, pcDNA3.1(+) vector group
and control group. The cells in the MPP+ group were treated with
10, 100, 250, or 500 lM MPP+ (Sigma, St. Louis, MO). The cells in
the heat shock group were treated with the same concentrations of
MPP+ 6 h after heat shock. In the transfected groups, 24 h after tran-
sient transfection of pcDNA3.1(+)/HDJ-1 plasmid or pcDNA3.1(+)
vector, cells were treated with the same concentrations of MPP+.
The control group contained cells without any treatment. All experi-
ments were completed within 24 h after MPP+ treatment.
2.4. Assay of cell viability
SK-N-SH cells were treated with MPP+ for 24 h. Cell viability was
measured by trypan blue exclusion test.
2.5. Real time polymerase chain reaction (PCR)
Total RNAs were extracted from cell suspensions using Trizol
according to the manufacturer’s instructions (Invitrogen). cDNA was
obtained from reverse transcription of 2 lg RNA. Primers and probes
were designed by TIBMOLBIOL Company (Berlin, Germany). Primer
sequences were as follows: sense: 5 0-AAAGGCCAAGGAGGGAGTT,
antisense: 5 0-CACCACTGCTCCTCCAACATT and Taqman probe:
FAM- CACTTGCTCTTTGGTCTTCTCAGCCACT-TAMRA for
a-synuclein; and sense: 5 0-TCACCCACACTGTGCCCATCTACTA-
3 0, antisense: 5 0-CATCGGAACCGCTCATTGCCGATAG-3 0 and
Taqman probe: FAM-ACGCGCTCCCCCATGCCATCCTGCGT-
TAMRA for b-actin. The quantitative expression of a-synuclein was
normalized using internal control gene b-actin. Target gene con-
tent = (a-synuclein copy number/b-actin copy number) · 104. The re-
sult provided a-synuclein gene content per 10000 internal control genes.
2.6. Western blot analysis
To measure the expression of HSPs after heat shock, the cells in 6-
well plates underwent heat shock treatment and were harvested and
lysed after 4, 24 or 72 h. The cells transfected with HDJ-1 were har-
vested and lysed at 24, 48 or 72 h after transfection. In the other exper-
iments, cells were harvested after MPP+ treatment for 24 h. Protein
concentration was determined using a BCA protein assay kit (Pierce
Rockford, IL). Aliquots of cell lysates containing 20 lg of proteins
were separated by sodium dodecyl sulfate (SDS)–polyacrylamide gel
and transferred to PVDF membranes. The membranes were blocked
with 5% skim milk at 37 C for 1 h and incubated with mouse anti-
Hsp70 (1:1000, BD Transduction Lab, Franklin Lakes, NJ), rabbit
anti-HDJ-1 (1:10000, Stressgen, Victoria, BC, Canada), mouse anti-
a-synuclein (1:1000, Cell Signaling Technology, Beverly, MA), mouse
anti-ubiquitin (1:1000, Cell Signaling Technology) at 4 C overnight.
Horseradish peroxidase (HRP)-linked anti-mouse or anti-rabbit IgG
and ECL (Cell Signaling Technology) was added and bands were visu-
alized. Equal loading of samples was conﬁrmed by stripping mem-
branes and reprobing with a mouse anti-b-actin (1:5000, Abcam
Cambridge, UK) and HRP-linked anti-mouse IgG. Each experiment
was repeated with three independent treatment groups. The density
of each band of sample was compared with that of b-actin for statisti-
cal analysis.
2.7. 20S proteasome activity assay
Cells in ﬁve groups were harvested by cell scraper followed by homo-
genation in cold lysis buﬀer (10 mmol/L Tris–HCL, pH 7.8, 0.5 mmol/
L dithiothreitol, 5 mmol/L ATP, 0.035% SDS, and 5 mmol/L MgCL2)
and quantiﬁcation of protein concentration. 20S proteasome activityassay was performed according to the manufacturer’s instruction
(Chemicon, Temecula, CA). Brieﬂy, protein extractions were incu-
bated with proteasome substrate Suc-LLVY-AMC (500 lmol/L) at
37 C for 1 h. Fluorescence was read using a 380/460 nm ﬁlter set in
a ﬂuorometer.
2.8. Immunostaining
Immunoﬂourescence staining was performed as previously described
[11]. Sheep anti-a-synuclein polyclonal antibody (1:200 Chemicon) and
mouse anti-vimentin monoclonal antibody (1:40, Sigma) were applied
at 4 C overnight followed by incubation with FITC-conjugated anti-
mouse IgG (1:200 Biosource, Camarillo, CA) or rhodamine-conju-
gated anti-sheep IgG (1:200 Chemicon) at RT for 1 h in the dark. Cells
were washed with PBS and observed under a ﬂuorescence microscope.
2.9. Statistical analysis
Data are expressed as means ± standard error of the mean (S.E.M.).
One-way ANOVA was used to determine the signiﬁcance of diﬀerences
among groups. P values <0.05 were considered signiﬁcant. Statistical
tests were carried out using SAS 6.12 (SAS Institute, Cary, NC).3. Results
3.1. HSPs expression after heat shock and HDJ-1 transfection
We found that the expression of Hsp70 and HDJ-1 was in-
duced by heat shock (Fig. 1A). Four hours after heat shock
treatment, the expression of Hsp70 was signiﬁcantly higher
than that of control. In fact, 72 h later, the level of Hsp70 in
heat shock cells was nearly ﬁve times higher than that in con-
trol cells (data not shown). Expression of HDJ-1 peaked 4 h
after heat shock treatment and then fell down with time, but
it remained higher than that of control cells at 72 h
(Fig. 1A). As the increasing expression of Hsp70 and HDJ-1
occurred between 4 and 72 h after heat shock treatment, we
administered MPP+ 6 h after heat shock treatment and com-
pleted all experiments within 48 h in the following experiments.
Therefore, all procedures were performed during the course of
high expression of HSPs. Over-expression of HDJ-1 in SK-N-
SH cells which were transfected with plasmid pcDNA3.1(+)/
HDJ-1 was veriﬁed by Western blot analysis at 24, 48 and
72 h after transfection. At 24 h post-transfection, the level of
HDJ-1 protein was higher than that in control cells and plas-
mid pcDNA3.1(+)-transfected cells, suggesting that HDJ-1
gene was over-expressed. The expression of HDJ-1 protein
continued to increase at 72 h (Fig. 1B). To investigate the ef-
fects of HDJ-1 gene over-expression in SK-N-SH cells, we
administered MPP+ to the cells 24 h after transfection, and
all procedures were performed within 48 h of HDJ-1 gene
over-expression.
3.2. Cell viability of MPP+-treated cells
MPP+ decreased cell viability in a concentration dependent
manner (Fig. 2). Treated with low concentrations of MPP+
(6100 lM), cell viability decreased with no signiﬁcant statisti-
cal diﬀerence compared with control. High concentrations of
MPP+ (P 250 lM) reduced cell viability signiﬁcantly
(P < 0.01).
3.3. HSPs inhibit a-synuclein mRNA expression induced by
MPP+
Treatment for 24 h with low concentrations of MPP+ in-
creased the expression of a-synuclein mRNA in SK-N-SH
cells. 10 lM MPP+ treatment increased a-synuclein mRNA
Fig. 1. (A) At 4, 24, and 72 h after heat shock treatment, expression of HSPs in cells was observed. Expression of Hsp70 and HDJ-1signiﬁcantly
increased, b-actin was used as loading control. (B) Western blot analysis of HDJ-1 gene expression in SK-N-SH cells. HDJ-1 gene over-expressed in
pcDNA3.1(+)/HDJ-1 transfected cells at 24, 48, and 72 h after transfection, respectively. b-Actin was used as loading control.
Fig. 3. Real-time PCR analysis of a-synuclein mRNA levels in cells
subjected to MPP+ treatment for 24 h. MPP+ treatment (10–250 lM)
induced expression of a-synuclein mRNA in large amounts, but this
eﬀect decreased with increasing MPP+ concentrations. With 500 lM
MPP+ treatment, a-synuclein mRNA level in MPP+ treated cells did
not diﬀer from that in normal cells. Both heat shock and over-
expression of HDJ-1 signiﬁcantly inhibited the MPP+-induced increase
in a-synuclein mRNA expression and maintained it at normal levels.
Results are means ± S.E.M. from three diﬀerent experiments.
*P < 0.01 vs. control, heat shock group and HDJ-1 transfected group.
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ing MPP+ concentrations, a-synuclein mRNA level declined.
The a-synuclein mRNA levels in cells treated with 500 lM
MPP+ appeared normal (Fig. 3). Kuhn also found that a-syn-
uclein mRNA levels of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP)-treated mice gradually decreased over time,
ultimately to levels even lower than those found in normal
mice [21]. In heat shock treated cells and in HDJ-1 transfected
cells, a-synuclein mRNA levels did not increase with the same
concentrations of MPP+ treatment. Rather, a-synuclein
mRNA expression was maintained at normal levels (Fig. 3).
And in pcDNA3.1(+) vector group, the level of a-synuclein
mRNA was similar to that in MPP+ group.
3.4. HSPs increased ubiquitinated protein in SK-N-SH cells
The ubiquitin-proteasome pathway (UPP) is the major deg-
radation system in eukaryotic cells. This pathway can remove
mutated, damaged, or misfolded proteins. Proteins that were
only labeled with polyubiquitin chains can be recognized and
degraded by 26S proteasome. Thus, changes of ubiquitinated
proteins may reﬂect a-synuclein degradation as well as protein
degradation.
We found the ubiquitinated proteins in both MPP+ group
(Fig. 4A-a) and pcDNA3.1(+) vector group (data not shown)
increased mildly, but there was no signiﬁcant diﬀerence com-
pared with that in control group (Fig. 4B). Treatment of heat
shock cells with the same concentrations of MPP+ increasedFig. 2. Cell viability examined by trypan blue exclusion method. Only
high concentrations of MPP+ (P 250 lM) decreased cell viability
signiﬁcantly. *P < 0.01 vs. control.the amount of ubiquitinated protein to levels greater than that
in both normal cells and the MPP+ group (P < 0.01, Fig. 4A-
b). Just like the heat shock group, cells transfected with HDJ-1
gene also showed signiﬁcantly increased ubiquitinated protein
(Fig. 4A-c), and the amount of ubiquitinated proteins was the
same in heat shock group and transfected HDJ-1 group
(Fig. 4B).
3.5. HSPs activated proteasome
20S proteasome is the proteolytic core of 26S proteasome.
20S proteasome activity can serve as an index of the degrada-
tion of a-synuclein. We found that MPP+ treatment resulted
in an initially increasing and then declining trend in proteasome
activity. Following low and moderate concentration (10 and
100 lM, respectively) MPP+ treatment, proteasome activity in-
creased. When MPP+ concentration increased to 250 lM, pro-
teasome activity declined. MPP+ can induce HSPs expression
and HSPs can protect the function of proteasome [22,23].
Therefore, we postulate thatMPP+ causes an increase in endog-
enous heat shock proteins, and thus upregulates proteasome
activity. However, with increasing MPP+ concentrations, the
Fig. 4. (A) Western blot analysis of ubiquitinated proteins. a, MPP+ group; b, heat shock group; c, HDJ-1 transfected group. 1: marker; 2: control;
3–6: 10, 100, 250, 500 lM MPP+ treatment. MPP+ treatment did not increase ubiquitinated proteins in SK-N-SH cells. Heat shock signiﬁcantly
increased ubiquitinated proteins by more than threefolds in cells treated by MPP+ compared with those in normal cells. HDJ-1 over-expression also
increased the amount of ubiquitinated protein signiﬁcantly and there were no diﬀerence in the amount of ubiquitinated proteins between HDJ-1
transfected cells and heat shock cells. (B) Comparison of ubiquitinated protein among the MPP+ group, pcDNA3.1(+) vector group, heat shock
group and HDJ-1 transfection group, showed that both heat shock and HDJ-1 over-expression increased ubiquitinated proteins signiﬁcantly. Results
are means ± S.E.M. from three diﬀerent experiments. *P < 0.01 vs. control, MPP+ group, pcDNA3.1(+) vector group.
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the protective eﬀect of endogenous heat shock proteins. There-
fore, the proteasome activity signiﬁcantly decreased. In the heat
shock group, proteasome activity was signiﬁcantly higher than
that in normal cells and MPP+ group (P < 0.01). The trend of
proteasome activity change in HDJ-1 transfected cells was sim-
ilar to that in heat shock cells, except that the increasing protea-
some activity observed in HDJ-1 transfection was minor
compared with heat shock (P < 0.01, Fig. 5).
3.6. HSPs reduced a-synuclein protein assayed by Western blot
MPP+ treatment resulted in markedly elevation of a-synuc-
lein protein level (P < 0.01). The peak level of a-synuclein pro-
tein occurred with 500 lM MPP+ treatment (Fig. 6A-a). We
found the mRNA and protein level were not parallel. We pos-
tulate that insuﬃcient ubiquitination of a-synuclein and lower
level of proteasome activity results in more a-synuclein protein
in cells which treated with 500 lMMPP+. It is well known that
mRNA transcription develops before protein translation.
When the SK-N-SH cells were treated with 10 lM MPP+,
the a-synuclein mRNA was largely increased, however, only
part of it was translated into protein and the UPP was acti-vated, so the amount of a-synuclein protein in cells was rela-
tively lower. Heat shock and HDJ-1 over-expression could
signiﬁcantly inhibit the elevation of a-synuclein protein in-
duced by MPP+. Although the amount of a-synuclein protein
in 250 and 500 lM MPP+ treated cells slightly increased, but
they were still maintained at normal level (Fig. 6A-b,c). The
change of a-synuclein protein in pcDNA3.1(+) vector group
was the same as that in MPP+ group (Fig. 6B).
3.7. HSPs inhibited a-synuclein aggregation in MPP+-treated
cells
Aggresome is an intracytoplasmic inclusion recently re-
ported to be associated with Lewy body. The formation of
aggresome is accompanied by the redistribution of the interme-
diate ﬁlament protein vimentin, which surrounds the aggre-
gated matter and forms a cage-like structure. Vimentin is the
hallmark protein of aggresome [10].
Normally, there is only weak immunopositive reaction of
a-synuclein and vimentin, which are evenly distributed
throughout the cytoplasm (Fig. 7a–c). After treatment by
MPP+, immunoﬂuorescence of a-synuclein and vimentin was
enhanced with increasing MPP+ concentration over time.
Fig. 5. Changes in proteasome activity. Low concentrations of MPP+
increased proteasome activity, while high concentrations of MPP+
inhibited proteasome activity. Both heat shock and HDJ-1 over-
expression elevated proteasome activity signiﬁcantly. The heat shock
eﬀect was pronounced. Results are means ± S.E.M. from three
diﬀerent experiments. *P < 0.01 vs. control; #P < 0.01 vs. MPP+
group and pcDNA3.1(+) vector group; nP < 0.01 vs. HDJ-1 trans-
fected group.
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and formation of ﬁbrils co-localized with vimentin in the per-
inuclear regions (Fig. 7d–f). But no typical a-synuclein-positive
aggresome could be detected. In the heat shock group, the
immunoﬂuorescence of a-synuclein and vimentin was slowly
enhanced with increasing MPP+ concentrations over time.
But a-synuclein and vimentin immunoﬂuorescence was still
evenly distributed in cells following 500 lM MPP+ treatment
(Fig. 7g–i). No ﬁbrils co-localized with a-synuclein and vimen-
tin could be found in cells. And in HDJ-1 over-expressed cells,
there were no ﬁbrils either (Fig. 7j–l).Fig. 6. (A) Western blot analysis of a-synuclein protein. a,d: MPP+ group; b,
b-actin which was used as loading control. 1: control; 2–5: 10, 100, 250, 5
proteins increased signiﬁcantly with the increasing of MPP+ concentration
molecular weight a-synuclein proteins elevation and maintained them at norm
*P < 0.01 vs. control, heat shock group and HDJ-1 transfected group.4. Discussion
MPTP exposure can markedly increase a-synuclein mRNA
expression [24]. MPP+, as an active metabolic product of
MPTP in brain, can induce a-synuclein nitration as well as
upregulate a-synuclein expression [25–27]. Moreover, MPP+-
induced oxidative stress promotes a-synuclein aggregation
[28]. Our study found that low concentrations MPP+ treatment
(6100 lM), which did not decrease cell viability signiﬁcantly,
induced large amounts of a-synuclein mRNA expression. It
suggested that the expression of a-synuclein mRNA was prior
to cell damage. And with the increase of MPP+ concentration,
a-synuclein mRNA expression was gradually decreased. HSPs
protect dopaminergic neuron against MPTP/MPP+-induced
neurotoxicity, correct protein misfolding or promote misfolded
protein degradation [29,30]. Previous studies generally focused
on the ability of HSPs to inhibit the formation of inclusions. In
this study, we found HSPs could keep a-synuclein mRNA at
normal levels after MPP+ treatment and HDJ-1 over-expres-
sion had the same eﬀect.
To measure the degradation of a-synuclein, we studied the
amount of ubiquitinated proteins and proteasome activity.
Inhibition of proteasome resulted in increasing of SDS-insolu-
ble a-synuclein and formation of cytoplasmic inclusions that
were positive for a-synuclein immunostaining [31]. Therefore,
the degradation of a-synuclein may be mediated by this path-
way. In sporadic PD patients, the activity of three enzymes in
proteasome was decreased by 33–42% in the substantia nigra
compared to other brain regions, which led to accumulation
of ubiquitinated proteins [32]. The mutation or over-expression
of a-synuclein results in oxidative stress and mitochondrial
damage. Mitochondrial damage and oxidative stress can inhibit
UPP [33]. In addition, insoluble a-synuclein ﬁbrils and solu-
ble a-synuclein oligomers can directly suppress chymotrypsine: heat shock group; c,f: HDJ-1 transfected group. a–c: a-synuclein d–f:
00 lM MPP+ treatment. The high molecular weight alpha-synuclein
. (B) Heat shock and over-expression of HDJ-1 gene inhibited high
al level. Results are means ± S.E.M. from three diﬀerent experiments.
Fig. 7. a-Synuclein-positive aggregations in SK-N-SH cells assayed by double immunoﬂuorescence-labeling of a-synuclein and vimentin. a-
Synuclein: red ﬂuorescence; vimentin: green ﬂuorescence. Co-localization of a-synuclein and vimentin was observed by merging red and green
ﬂuorescence signals. (a–c) normal cells. (d–f) 100 lMMPP+ treated 24 h, ﬁbrillar aggregations co-localized with a-synuclein and vimentin were found
around the nucleus (arrows). (g–i): in heat shock cells treated with 500 lMMPP+ for 24 h, a-synuclein and vimentin were evenly distributed and no
aggregations could be found. (j–l): in HDJ-1 transfection cells treated with 500 lM MPP+ for 24 h, a-synuclein and vimentin were also evenly
distributed.
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concentration MPP+ exposure induced an increase in protea-
some activity, the ubiquitinated proteins did not elevate signif-
icantly. It means that the over-expressed a-synuclein induced
by MPP+ could not be ubiquitinated absolutely and degraded
in time. Therefore, both increased a-synuclein mRNA tran-
scription and inhibition of a-synuclein degradation lead to
accumulation of a-synuclein protein in cells. Moreover, highconcentration MPP+ exposure reduced proteasome activity
signiﬁcantly, leading to more a-synuclein proteins accumulat-
ing in cells. Excessive a-synuclein is prone to form ﬁbrils.
Meanwhile, aggregated a-synuclein can inhibit proteasome
activity, creating an endless cycle. In MPP+-treated SK-N-SH
cells, there were no typical aggreasomes, but ﬁbril aggregates
surrounding the cellular nucleus, which is consistent with the
absence of Lewy bodies found in the MPTP-induced PD
G.-H. Fan et al. / FEBS Letters 580 (2006) 3091–3098 3097animal model. In previous studies mice developed motor
function impairment and decreased striatal DA content after
a-synuclein gene transfection, but a-synuclein ﬁbrils did not
form. It was speculated that the oligomer or protoﬁbril of
a-synuclein was more toxic to cells [34].
Cells transfected with HDJ-1 can maintain relatively high
proteasome activity levels during oxidative stress that sup-
presses chymotrypsin-like proteasome activity. Hsp70 can also
lessen the inhibitory eﬀects of a-synuclein on proteasomes [35].
Oxidation and aggregated proteins are able to suppress protea-
some’s activity, but HSPs can reduce protein aggregation, so
as to protect proteasome activity. We found that both heat
shock and HDJ-1 over-expression could signiﬁcantly increase
protein ubiquitination, and enhance proteasome activity.
Therefore, the excessively produced a-synuclein induced by
MPP+ could be quickly degraded through this pathway. But
pcDNA3.1(+) vector transfection had no inhibit eﬀect on a-
synuclein, so the changes related to HDJ-1 transfection were
speciﬁc to the HDJ-1 gene. And HDJ-1 may play an important
role in HSPs’ eﬀect on a-synuclein, because the amount of a-
synuclein protein and a-synuclein aggregation were similar in
heat shock group and HDJ-1 transfection group. HSPs can in-
hibit a-synuclein synthesis and increase a-synuclein degrada-
tion, resulting in a decrease of a-synuclein protein amounts
and preventing a-synuclein aggregation. These eﬀects may pro-
vide a novel therapeutic strategy for PD treatment.
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